世界のインターロイキン1受容体関連キナーゼ4市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Interleukin 1 Receptor Associated Kinase 4 Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5805
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、インターロイキン1受容体関連キナーゼ4の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CA-4948、ND-2110、R-191、その他）、用途別市場規模（痛風性関節炎、パソリア症、急性骨髄性白血病、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・インターロイキン1受容体関連キナーゼ4の市場動向
・企業の競争状況、市場シェア
・インターロイキン1受容体関連キナーゼ4の種類別市場規模と予測2016-2027（CA-4948、ND-2110、R-191、その他）
・インターロイキン1受容体関連キナーゼ4の用途別市場規模と予測2016-2027（痛風性関節炎、パソリア症、急性骨髄性白血病、その他）
・インターロイキン1受容体関連キナーゼ4の北米市場規模2016-2027（アメリカ、カナダ）
・インターロイキン1受容体関連キナーゼ4の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・インターロイキン1受容体関連キナーゼ4のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・インターロイキン1受容体関連キナーゼ4の中南米市場規模2016-2027（メキシコ、ブラジル）
・インターロイキン1受容体関連キナーゼ4の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Amgen Inc、Astellas Pharma Inc、Aurigene Discovery Technologies Ltd、Beijing Hanmi Pharmaceutical Co Ltd、Genentech Inc、Merck & Co Inc、Rigel Pharmaceuticals Inc、TG Therapeutics Inc）
・結論

Market Analysis and Insights: Global Interleukin 1 Receptor Associated Kinase 4 Market
The global Interleukin 1 Receptor Associated Kinase 4 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Interleukin 1 Receptor Associated Kinase 4 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Interleukin 1 Receptor Associated Kinase 4 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Interleukin 1 Receptor Associated Kinase 4 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Interleukin 1 Receptor Associated Kinase 4 market.

Global Interleukin 1 Receptor Associated Kinase 4 Scope and Market Size
Interleukin 1 Receptor Associated Kinase 4 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Interleukin 1 Receptor Associated Kinase 4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CA-4948
ND-2110
R-191
Others

Segment by Application
Gouty Arthritis
Pasoriasis
Acute Myelocytic Leukemia
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen Inc
Astellas Pharma Inc
Aurigene Discovery Technologies Ltd
Beijing Hanmi Pharmaceutical Co Ltd
Genentech Inc
Merck & Co Inc
Rigel Pharmaceuticals Inc
TG Therapeutics Inc

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interleukin 1 Receptor Associated Kinase 4 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CA-4948
1.2.3 ND-2110
1.2.4 R-191
1.2.5 Others
1.3 Market by Application
1.3.1 Global Interleukin 1 Receptor Associated Kinase 4 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Gouty Arthritis
1.3.3 Pasoriasis
1.3.4 Acute Myelocytic Leukemia
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Interleukin 1 Receptor Associated Kinase 4 Market Perspective (2016-2027)
2.2 Interleukin 1 Receptor Associated Kinase 4 Growth Trends by Regions
2.2.1 Interleukin 1 Receptor Associated Kinase 4 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Interleukin 1 Receptor Associated Kinase 4 Historic Market Share by Regions (2016-2021)
2.2.3 Interleukin 1 Receptor Associated Kinase 4 Forecasted Market Size by Regions (2022-2027)
2.3 Interleukin 1 Receptor Associated Kinase 4 Industry Dynamic
2.3.1 Interleukin 1 Receptor Associated Kinase 4 Market Trends
2.3.2 Interleukin 1 Receptor Associated Kinase 4 Market Drivers
2.3.3 Interleukin 1 Receptor Associated Kinase 4 Market Challenges
2.3.4 Interleukin 1 Receptor Associated Kinase 4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Interleukin 1 Receptor Associated Kinase 4 Players by Revenue
3.1.1 Global Top Interleukin 1 Receptor Associated Kinase 4 Players by Revenue (2016-2021)
3.1.2 Global Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Players (2016-2021)
3.2 Global Interleukin 1 Receptor Associated Kinase 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Interleukin 1 Receptor Associated Kinase 4 Revenue
3.4 Global Interleukin 1 Receptor Associated Kinase 4 Market Concentration Ratio
3.4.1 Global Interleukin 1 Receptor Associated Kinase 4 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interleukin 1 Receptor Associated Kinase 4 Revenue in 2020
3.5 Interleukin 1 Receptor Associated Kinase 4 Key Players Head office and Area Served
3.6 Key Players Interleukin 1 Receptor Associated Kinase 4 Product Solution and Service
3.7 Date of Enter into Interleukin 1 Receptor Associated Kinase 4 Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Interleukin 1 Receptor Associated Kinase 4 Breakdown Data by Type
4.1 Global Interleukin 1 Receptor Associated Kinase 4 Historic Market Size by Type (2016-2021)
4.2 Global Interleukin 1 Receptor Associated Kinase 4 Forecasted Market Size by Type (2022-2027)

5 Interleukin 1 Receptor Associated Kinase 4 Breakdown Data by Application
5.1 Global Interleukin 1 Receptor Associated Kinase 4 Historic Market Size by Application (2016-2021)
5.2 Global Interleukin 1 Receptor Associated Kinase 4 Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Interleukin 1 Receptor Associated Kinase 4 Market Size (2016-2027)
6.2 North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Type
6.2.1 North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2021)
6.2.2 North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2022-2027)
6.2.3 North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2027)
6.3 North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Application
6.3.1 North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2016-2021)
6.3.2 North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2022-2027)
6.3.3 North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2016-2027)
6.4 North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Country
6.4.1 North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2016-2021)
6.4.2 North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Interleukin 1 Receptor Associated Kinase 4 Market Size (2016-2027)
7.2 Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Type
7.2.1 Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2021)
7.2.2 Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2022-2027)
7.2.3 Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2027)
7.3 Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Application
7.3.1 Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2016-2021)
7.3.2 Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2022-2027)
7.3.3 Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2016-2027)
7.4 Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Country
7.4.1 Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2016-2021)
7.4.2 Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size (2016-2027)
8.2 Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Type
8.2.1 Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2027)
8.3 Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Application
8.3.1 Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2016-2027)
8.4 Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Region
8.4.1 Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size (2016-2027)
9.2 Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Type
9.2.1 Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2021)
9.2.2 Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2022-2027)
9.2.3 Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2027)
9.3 Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Application
9.3.1 Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2016-2021)
9.3.2 Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2022-2027)
9.3.3 Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2016-2027)
9.4 Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Country
9.4.1 Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2016-2021)
9.4.2 Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size (2016-2027)
10.2 Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Type
10.2.1 Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2027)
10.3 Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Application
10.3.1 Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2016-2027)
10.4 Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Country
10.4.1 Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Details
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc Interleukin 1 Receptor Associated Kinase 4 Introduction
11.1.4 Amgen Inc Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
11.1.5 Amgen Inc Recent Development
11.2 Astellas Pharma Inc
11.2.1 Astellas Pharma Inc Company Details
11.2.2 Astellas Pharma Inc Business Overview
11.2.3 Astellas Pharma Inc Interleukin 1 Receptor Associated Kinase 4 Introduction
11.2.4 Astellas Pharma Inc Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
11.2.5 Astellas Pharma Inc Recent Development
11.3 Aurigene Discovery Technologies Ltd
11.3.1 Aurigene Discovery Technologies Ltd Company Details
11.3.2 Aurigene Discovery Technologies Ltd Business Overview
11.3.3 Aurigene Discovery Technologies Ltd Interleukin 1 Receptor Associated Kinase 4 Introduction
11.3.4 Aurigene Discovery Technologies Ltd Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
11.3.5 Aurigene Discovery Technologies Ltd Recent Development
11.4 Beijing Hanmi Pharmaceutical Co Ltd
11.4.1 Beijing Hanmi Pharmaceutical Co Ltd Company Details
11.4.2 Beijing Hanmi Pharmaceutical Co Ltd Business Overview
11.4.3 Beijing Hanmi Pharmaceutical Co Ltd Interleukin 1 Receptor Associated Kinase 4 Introduction
11.4.4 Beijing Hanmi Pharmaceutical Co Ltd Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
11.4.5 Beijing Hanmi Pharmaceutical Co Ltd Recent Development
11.5 Genentech Inc
11.5.1 Genentech Inc Company Details
11.5.2 Genentech Inc Business Overview
11.5.3 Genentech Inc Interleukin 1 Receptor Associated Kinase 4 Introduction
11.5.4 Genentech Inc Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
11.5.5 Genentech Inc Recent Development
11.6 Merck & Co Inc
11.6.1 Merck & Co Inc Company Details
11.6.2 Merck & Co Inc Business Overview
11.6.3 Merck & Co Inc Interleukin 1 Receptor Associated Kinase 4 Introduction
11.6.4 Merck & Co Inc Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
11.6.5 Merck & Co Inc Recent Development
11.7 Rigel Pharmaceuticals Inc
11.7.1 Rigel Pharmaceuticals Inc Company Details
11.7.2 Rigel Pharmaceuticals Inc Business Overview
11.7.3 Rigel Pharmaceuticals Inc Interleukin 1 Receptor Associated Kinase 4 Introduction
11.7.4 Rigel Pharmaceuticals Inc Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
11.7.5 Rigel Pharmaceuticals Inc Recent Development
11.8 TG Therapeutics Inc
11.8.1 TG Therapeutics Inc Company Details
11.8.2 TG Therapeutics Inc Business Overview
11.8.3 TG Therapeutics Inc Interleukin 1 Receptor Associated Kinase 4 Introduction
11.8.4 TG Therapeutics Inc Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
11.8.5 TG Therapeutics Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Interleukin 1 Receptor Associated Kinase 4 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CA-4948
Table 3. Key Players of ND-2110
Table 4. Key Players of R-191
Table 5. Key Players of Others
Table 6. Global Interleukin 1 Receptor Associated Kinase 4 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Interleukin 1 Receptor Associated Kinase 4 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Interleukin 1 Receptor Associated Kinase 4 Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Interleukin 1 Receptor Associated Kinase 4 Market Share by Regions (2016-2021)
Table 10. Global Interleukin 1 Receptor Associated Kinase 4 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Interleukin 1 Receptor Associated Kinase 4 Market Share by Regions (2022-2027)
Table 12. Interleukin 1 Receptor Associated Kinase 4 Market Trends
Table 13. Interleukin 1 Receptor Associated Kinase 4 Market Drivers
Table 14. Interleukin 1 Receptor Associated Kinase 4 Market Challenges
Table 15. Interleukin 1 Receptor Associated Kinase 4 Market Restraints
Table 16. Global Interleukin 1 Receptor Associated Kinase 4 Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Interleukin 1 Receptor Associated Kinase 4 Market Share by Players (2016-2021)
Table 18. Global Top Interleukin 1 Receptor Associated Kinase 4 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interleukin 1 Receptor Associated Kinase 4 as of 2020)
Table 19. Ranking of Global Top Interleukin 1 Receptor Associated Kinase 4 Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Interleukin 1 Receptor Associated Kinase 4 Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Interleukin 1 Receptor Associated Kinase 4 Product Solution and Service
Table 23. Date of Enter into Interleukin 1 Receptor Associated Kinase 4 Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Type (2016-2021)
Table 27. Global Interleukin 1 Receptor Associated Kinase 4 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Interleukin 1 Receptor Associated Kinase 4 Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Application (2016-2021)
Table 31. Global Interleukin 1 Receptor Associated Kinase 4 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size by Country (2022-2027) & (US$ Million)
Table 63. Amgen Inc Company Details
Table 64. Amgen Inc Business Overview
Table 65. Amgen Inc Interleukin 1 Receptor Associated Kinase 4 Product
Table 66. Amgen Inc Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021) & (US$ Million)
Table 67. Amgen Inc Recent Development
Table 68. Astellas Pharma Inc Company Details
Table 69. Astellas Pharma Inc Business Overview
Table 70. Astellas Pharma Inc Interleukin 1 Receptor Associated Kinase 4 Product
Table 71. Astellas Pharma Inc Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021) & (US$ Million)
Table 72. Astellas Pharma Inc Recent Development
Table 73. Aurigene Discovery Technologies Ltd Company Details
Table 74. Aurigene Discovery Technologies Ltd Business Overview
Table 75. Aurigene Discovery Technologies Ltd Interleukin 1 Receptor Associated Kinase 4 Product
Table 76. Aurigene Discovery Technologies Ltd Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021) & (US$ Million)
Table 77. Aurigene Discovery Technologies Ltd Recent Development
Table 78. Beijing Hanmi Pharmaceutical Co Ltd Company Details
Table 79. Beijing Hanmi Pharmaceutical Co Ltd Business Overview
Table 80. Beijing Hanmi Pharmaceutical Co Ltd Interleukin 1 Receptor Associated Kinase 4 Product
Table 81. Beijing Hanmi Pharmaceutical Co Ltd Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021) & (US$ Million)
Table 82. Beijing Hanmi Pharmaceutical Co Ltd Recent Development
Table 83. Genentech Inc Company Details
Table 84. Genentech Inc Business Overview
Table 85. Genentech Inc Interleukin 1 Receptor Associated Kinase 4 Product
Table 86. Genentech Inc Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021) & (US$ Million)
Table 87. Genentech Inc Recent Development
Table 88. Merck & Co Inc Company Details
Table 89. Merck & Co Inc Business Overview
Table 90. Merck & Co Inc Interleukin 1 Receptor Associated Kinase 4 Product
Table 91. Merck & Co Inc Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021) & (US$ Million)
Table 92. Merck & Co Inc Recent Development
Table 93. Rigel Pharmaceuticals Inc Company Details
Table 94. Rigel Pharmaceuticals Inc Business Overview
Table 95. Rigel Pharmaceuticals Inc Interleukin 1 Receptor Associated Kinase 4 Product
Table 96. Rigel Pharmaceuticals Inc Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021) & (US$ Million)
Table 97. Rigel Pharmaceuticals Inc Recent Development
Table 98. TG Therapeutics Inc Company Details
Table 99. TG Therapeutics Inc Business Overview
Table 100. TG Therapeutics Inc Revenue in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021) & (US$ Million)
Table 101. TG Therapeutics Inc Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Interleukin 1 Receptor Associated Kinase 4 Market Share by Type: 2020 VS 2027
Figure 2. CA-4948 Features
Figure 3. ND-2110 Features
Figure 4. R-191 Features
Figure 5. Others Features
Figure 6. Global Interleukin 1 Receptor Associated Kinase 4 Market Share by Application: 2020 VS 2027
Figure 7. Gouty Arthritis Case Studies
Figure 8. Pasoriasis Case Studies
Figure 9. Acute Myelocytic Leukemia Case Studies
Figure 10. Others Case Studies
Figure 11. Interleukin 1 Receptor Associated Kinase 4 Report Years Considered
Figure 12. Global Interleukin 1 Receptor Associated Kinase 4 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Interleukin 1 Receptor Associated Kinase 4 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Interleukin 1 Receptor Associated Kinase 4 Market Share by Regions: 2020 VS 2027
Figure 15. Global Interleukin 1 Receptor Associated Kinase 4 Market Share by Regions (2022-2027)
Figure 16. Global Interleukin 1 Receptor Associated Kinase 4 Market Share by Players in 2020
Figure 17. Global Top Interleukin 1 Receptor Associated Kinase 4 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interleukin 1 Receptor Associated Kinase 4 as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Interleukin 1 Receptor Associated Kinase 4 Revenue in 2020
Figure 19. Global Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Type (2016-2021)
Figure 20. Global Interleukin 1 Receptor Associated Kinase 4 Revenue Market Share by Type (2022-2027)
Figure 21. North America Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Interleukin 1 Receptor Associated Kinase 4 Market Share by Type (2016-2027)
Figure 23. North America Interleukin 1 Receptor Associated Kinase 4 Market Share by Application (2016-2027)
Figure 24. North America Interleukin 1 Receptor Associated Kinase 4 Market Share by Country (2016-2027)
Figure 25. United States Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Interleukin 1 Receptor Associated Kinase 4 Market Share by Type (2016-2027)
Figure 29. Europe Interleukin 1 Receptor Associated Kinase 4 Market Share by Application (2016-2027)
Figure 30. Europe Interleukin 1 Receptor Associated Kinase 4 Market Share by Country (2016-2027)
Figure 31. Germany Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Interleukin 1 Receptor Associated Kinase 4 Market Share by Region (2016-2027)
Figure 41. China Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Interleukin 1 Receptor Associated Kinase 4 Market Share by Type (2016-2027)
Figure 49. Latin America Interleukin 1 Receptor Associated Kinase 4 Market Share by Application (2016-2027)
Figure 50. Latin America Interleukin 1 Receptor Associated Kinase 4 Market Share by Country (2016-2027)
Figure 51. Mexico Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Interleukin 1 Receptor Associated Kinase 4 Market Share by Country (2016-2027)
Figure 57. Turkey Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Interleukin 1 Receptor Associated Kinase 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Inc Revenue Growth Rate in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
Figure 61. Astellas Pharma Inc Revenue Growth Rate in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
Figure 62. Aurigene Discovery Technologies Ltd Revenue Growth Rate in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
Figure 63. Beijing Hanmi Pharmaceutical Co Ltd Revenue Growth Rate in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
Figure 64. Genentech Inc Revenue Growth Rate in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
Figure 65. Merck & Co Inc Revenue Growth Rate in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
Figure 66. Rigel Pharmaceuticals Inc Revenue Growth Rate in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
Figure 67. TG Therapeutics Inc Revenue Growth Rate in Interleukin 1 Receptor Associated Kinase 4 Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界のインターロイキン12受容体市場規模・現状・予測（2021年-2027年）

Global Interleukin 12 Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5806 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、インターロイキン12受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エドデキンアルファSR、M-9241、LY-3232094、NMIL-121、その他）、用途別市場規模（入院患者、外来患者）、...

世界のチロシンプロテインキナーゼ受容体TYRO3市場規模・現状・予測（2021年-2027年）

Global Tyrosine Protein Kinase Receptor TYRO3 Market Size, Status and Forecast 2021-2027
QFJ1-6057 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、チロシンプロテインキナーゼ受容体TYRO3の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（RXDX-106、ELB-031、Q-701、その他）、用途別市場規模（膀胱がん、乳がん、転移性大腸がん、卵巣...

世界のプロテインキナーゼCイプシロン型市場規模・現状・予測（2021年-2027年）

Global Protein Kinase C Epsilon Type Market Size, Status and Forecast 2021-2027
QFJ1-5970 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、プロテインキナーゼCイプシロン型の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブリオスタチン-1、DHACP-6、VMD-1201、その他）、用途別市場規模（アルコール依存症、頭頸部がん、虚血性脳卒...

世界のヤヌスキナーゼ（JAK）阻害剤市場規模・現状・予測（2021年-2027年）

Global Janus Kinase (JAK) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5815 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ヤヌスキナーゼ（JAK）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ルキソリチニブ、トファシチニブ、オクラシチニブ、バリシチニブ、ペフィシチニブ）、用途別市場規模（自己免疫疾患、腫瘍）、主要...

世界のPI3キナーゼ（PI3K）阻害剤市場規模・現状・予測（2021年-2027年）

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5949 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、PI3キナーゼ（PI3K）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CLL-慢性リンパ性白血病、FL-濾胞性リンパ腫、その他疾患）、用途別市場規模（病院、研究所・研究機関、クリニック、その...

インターロイキン7受容体サブユニットアルファのグローバル市場調査 2019年

Global Interleukin 7 Receptor Subunit Alpha Market Professional Survey Report 2019
QYR9NV06980 2019年11月12日 101Pages
※本調査レポートは、インターロイキン7受容体サブユニットアルファの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CYT-107、GSK-2618960、GX-...

世界のクレアチンキナーゼテスト市場規模・現状・予測（2021年-2027年）

Global Creatine Kinase Test Market Size, Status and Forecast 2021-2027
QFJ1-4064 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、クレアチンキナーゼテストの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（心筋梗塞、うっ血性心不全）、用途別市場規模（臨床検査、ポイントオブケア検査）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界のC-X-Cケモカイン受容体タイプ1市場規模・現状・予測（2021年-2027年）

Global C-X-C Chemokine Receptor Type 1 Market Size, Status and Forecast 2021-2027
QFJ1-5683 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、C-X-Cケモカイン受容体タイプ1の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（DF-2755A、PAC-G31P、レパリキシン、SX-576、その他）、用途別市場規模（炎症、肺がん、黒色腫、術後痛...

世界のエフリンB型受容体4市場規模・現状・予測（2021年-2027年）

Global Ephrin Type B Receptor 4 Market Size, Status and Forecast 2021-2027
QFJ1-5725 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、エフリンB型受容体4の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（VDAU-11、Vas-01、トシレートテセバチニブ、その他）、用途別市場規模（固形腫瘍、胆管がん、結腸直腸がん、黒色腫、その他）、...

世界のN-ホルミルペプチド受容体2市場規模・現状・予測（2021年-2027年）

Global N-Formyl Peptide Receptor 2 Market Size, Status and Forecast 2021-2027
QFJ1-5886 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、N-ホルミルペプチド受容体2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（TR-8、NCP-70X、ヒューマニン、その他）、用途別市場規模（炎症、2型糖尿病、アレルギー、脳虚血、転移性がん、その他）...

世界のインターロイキン12受容体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Interleukin 12 Receptor Market The global Interleukin 12 Receptor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the re…
世界のチロシンプロテインキナーゼ受容体TYRO3市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tyrosine Protein Kinase Receptor TYRO3 Market The global Tyrosine Protein Kinase Receptor TYRO3 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…
インターロイキン7受容体サブユニットアルファのグローバル市場調査 2019年 The global Interleukin 7 Receptor Subunit Alpha market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Interleukin 7 Receptor Subunit Alpha volume and value at global level, regional level and company leve…
非受容体チロシンプロテインキナーゼTYK2のグローバル市場調査 2019年 The global Non Receptor Tyrosine Protein Kinase TYK2 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Non Receptor Tyrosine Protein Kinase TYK2 volume and value at global level, regional level and co…
受容体型チロシンプロテインキナーゼのグローバル市場調査 2019年 The global Receptor Tyrosine Protein Kinase ERBB 4 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Receptor Tyrosine Protein Kinase ERBB 4 volume and value at global level, regional level and compan…